Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept
Clinical trial NCT02125864 · COMPLETED
Trial details
- NCT number
- NCT02125864
- Sponsor
- Oslo University Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2014-11-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.